Artemether-lumefantrine nanostructured lipid carriers for oral malaria therapy: Enhanced efficacy at reduced dose and dosing frequency.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  International journal of pharmaceutics

• Publication date

  2016-09-10

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.ijpharm.2016.07.021PMID 27421912
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanostructured lipid carriers and their current application in targeted drug delivery

  2016cited by this paper
• Artemisinin-based combination therapy in the treatment of uncomplicated malaria: review of recent regulatory experience at the European Medicines Agency

  2015cited by this paper
• Evaluation of 2-week repeated oral dose toxicity of 100 nm zinc oxide nanoparticles in rats

  2015cited by this paper
• Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems

  2014cited by this paper
• Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.

  2014cited by this paper
• Pharmaceutical and biomedical applications of lipid-based nanocarriers.

  2014cited by this paper
• Enhanced Antimalarial Activity by a Novel Artemether-Lumefantrine Lipid Emulsion for Parenteral Administration

  2014cited by this paper
• Nanostructured lipid carriers as a novel oral delivery system for triptolide: induced changes in pharmacokinetics profile associated with reduced toxicity in male rats

  2014cited by this paper
• Formulation and characterization of atovaquone nanosuspension for improved oral delivery in the treatment of malaria.

  2014cited by this paper
• Lipid-Based Drug Delivery Systems

  2014cited by this paper
• Solid lipid nanoparticles enhance oral bioavailability of resveratrol, a natural polyphenol

  2014cited by this paper
• Pharmacokinetics study of arteether loaded solid lipid nanoparticles: an improved oral bioavailability in rats.

  2014cited by this paper
• Investigation of the Functional Role of P-Glycoprotein in Limiting the Oral Bioavailability of Lumefantrine

  2013cited by this paper
• Nanocarriers for oral drug delivery

  2013cited by this paper
• Recent advances in particulate anti-malarial drug delivery systems: A review

  2013cited by this paper
• Testosterone undecanoate – increase of oral bioavailability by nanostructured lipid carriers (NLC)

  2013cited by this paper
• ARTEETHER- LOADED SOLID LIPID NANOPARTICULATE DISPERSION: DESIGN AND CHARACTERIZATION

  2013cited by this paper
• Evaluation of novel lipid based formulation of β-Artemether and Lumefantrine in murine malaria model.

  2013cited by this paper
• Improvement of drug safety by the use of lipid-based nanocarriers.

  2012cited by this paper
• Formulation design and in vivo antimalarial evaluation of lipid-based drug delivery systems for oral delivery of β-arteether.

  2012cited by this paper
• Clotrimazole nanoemulsion for malaria chemotherapy. Part II: stability assessment, in vivo pharmacodynamic evaluations and toxicological studies.

  2012cited by this paper
• Intravenous β-artemether formulation (ARM NLC) as a superior alternative to commercial artesunate formulation.

  2012cited by this paper
• Lipospheres and pro-nano lipospheres for delivery of poorly water soluble compounds.

  2012cited by this paper
• Clotrimazole nanoemulsion for malaria chemotherapy. Part I: preformulation studies, formulation design and physicochemical evaluation.

  2012cited by this paper
• Malaria vector control: from past to future

  2011cited by this paper
• Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro.

  2011cited by this paper
• Fluvoxamine versus other anti-depressive agents for depression.

  2010cited by this paper
• Coartem®: the journey to the clinic

  2009cited by this paper
• Ongoing challenges in the management of malaria

  2009cited by this paper
• The international conference on harmonisation of technical requirements for registration of pharmaceuticals for human use

  2009cited by this paper
• Drug Nanoparticles: Formulating Poorly Water-Soluble Compounds

  2008cited by this paper
• Solid microemulsion preconcentrate (NanOsorb) of artemether for effective treatment of malaria.

  2008cited by this paper
• Design and in vivo pharmacodynamic evaluation of nanostructured lipid carriers for parenteral delivery of artemether: Nanoject.

  2008cited by this paper
• Challenges facing drug development for malaria.

  2008cited by this paper
• Artemether/lumefantrine in the treatment of uncomplicated falciparum malaria

  2007cited by this paper
• Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules

  2006cited by this paper
• In vitro investigation on the impact of the surface-active excipients Cremophor EL, Tween 80 and Solutol HS 15 on the metabolism of midazolam.

  2004cited by this paper
• Artemether-lumefantrine for treating uncomplicated falciparum malaria.

  2003cited by this paper
• Malaria pathogenesis: a jigsaw with an increasing number of pieces.

  2002cited by this paper
• Potential inhibitory effects of formulation ingredients on intestinal cytochrome P450.

  2000cited by this paper
• Pharmacokinetics and Pharmacodynamics of Lumefantrine (Benflumetol) in Acute Falciparum Malaria

  2000cited by this paper
• Clinical Pharmacokinetics of Artemether and Lumefantrine (Riamet®)

  1999cited by this paper
• Solutol HS 15, nontoxic polyoxyethylene esters of 12-hydroxystearic acid, reverses multidrug resistance.

  1991cited by this paper

• Comparative larvicidal, pupicidal, adulticidal activity of Artemisia nilagirica (C.B. Cl) Pamp extract in controlling Culex quinquefasciatus, Anopheles stephensi, Aedes aegypti and Aedes albopictus.

  2025cites this paper
• Emerging nanotechnology-driven drug delivery solutions for malaria: Addressing drug resistance and improving therapeutic success.

  2025cites this paper
• Oligochitosan Conjugates of the Antimalarials Dihydroartemisinin and Lumefantrine: Synthesis, Stability, Cell Viability, and Antiplasmodial Studies

  2025cites this paper
• Nanoformulation and Preclinical Evaluation of Dihydroartemisinin–Lumefantrine and Primaquine as Combined Antimalarial Therapy

  2025cites this paper
• Incompatibility of antimalarial drugs: challenges in formulating combination products for malaria

  2024cites this paper
• Effects of nanocapsules containing lumefantrine and artemether in an experimental model of cerebral malaria

  2024influential citation
• Nanotechnology based drug delivery systems for malaria.

  2024cites this paper
• Recent Advancement in Drug Development for Treating Malaria using Herbal Medicine and Nanotechnological Approach.

  2024cites this paper
• The Advances in Phospholipids-Based Phase Separation Gels for the Sustained Release of Peptides, Proteins, and Chemotherapeutics

  2024cites this paper
• Biomolecular interactions between Plasmodium and human host: A basis of targeted antimalarial therapy.

  2024cites this paper
• NANOPARTICLE-BASED formulation of dihydroartemisinin-lumefantrine duo-drugs: Preclinical Evaluation and enhanced antimalarial efficacy in a mouse model

  2024cites this paper
• Fixed-Dose Combination Formulations in Solid Oral Drug Therapy: Advantages, Limitations, and Design Features

  2024cites this paper
• Exploring the potential of antimalarial nanocarriers as a novel therapeutic approach.

  2023cites this paper
• Nanostructured Lipid Carriers for Improved Delivery of Therapeutics via the Oral Route

  2023cites this paper
• Nanocarrier based active targeting strategies against erythrocytic stage of malaria.

  2023cites this paper
• Opportunity in nanomedicine to counter the challenges of current drug delivery approaches used for the treatment of malaria: a review

  2023cites this paper
• Solidification of Self-Emulsifying Drug Delivery Systems as a Novel Approach to the Management of Uncomplicated Malaria

  2022cites this paper
• Evaluation of Pharmacokinetics, Biodistribution, and Antimalarial Efficacy of Artemether-Loaded Polymeric Nanorods.

  2022cites this paper
• Compatibilized Biopolymer-based Core–shell Nanoparticles: A New Frontier in Malaria Combo-therapy

  2022cites this paper
• Nanostructured lipid carriers and their potential applications for versatile drug delivery via oral administration

  2022cites this paper
• Current challenges and nanotechnology-based pharmaceutical strategies for the treatment and control of malaria

  2022cites this paper
• Bioavailability Enhancement of Artemether and Lumefantrine by Improving Solubility and Dissolution Rate using Solid Dispersion Technique

  2021cites this paper
• Pharmacokinetics and antimalarial activities of reduction-responsive releasing dihydroartemisinin prodrug self-assembled nanoparticles in rodents

  2021cites this paper
• Development of nanocarriers for innovative antimalarial combination strategies

  2021cites this paper
• New Drug Discovery and Development in India to Counter Malaria

  2021cites this paper
• Improved Bioavailability of Poorly Soluble Drugs through Gastrointestinal Muco-Adhesion of Lipid Nanoparticles

  2021cites this paper
• Long noncoding RNA PTENP1 affects the recovery of spinal cord injury by regulating the expression of miR‐19b and miR‐21

  2020cites this paper
• Encapsulation and delivery of antiparasitic drugs: a review

  2020cites this paper
• NANOEMULSION COMPOSED OF 10-(4,5-DIHYDROTHIAZOL-2-YL)THIO)DECAN-1-OL), A SYNTHETIC ANALOG OF 3-ALKYLPIRIDINE MARINE ALKALOID: DEVELOPMENT, CHARACTERIZATION, AND ANTIMALARIAL ACTIVITY.

  2020cites this paper
• Improved antimalarial activity of caprol-based nanostructured lipid carriers encapsulating artemether-lumefantrine for oral administration

  2020cites this paper
• Nano-facilitated drug delivery strategies in the treatment of plasmodium infection.

  2019cites this paper
• Combination drug therapy via nanocarriers against infectious diseases.

  2019cites this paper
• Properties and therapeutic potential of solid lipid nanoparticles and nanostructured lipid carriers as promising colloidal drug delivery systems

  2019cites this paper
• Efficient weapon for protracted warfare to malaria: A chondroitin sulfate derivates-containing injectable, ultra-long-lasting meshy-gel system.

  2019cites this paper
• Nanosoldiers: A promising strategy to combat triple negative breast cancer.

  2019cites this paper
• Development of lipid matrix tablets containing a double-fixed dose combination of artemether and lumefantrine

  2019cites this paper
• Atovaquone oral bioavailability enhancement using electrospraying technology

  2018cites this paper
• Development of lipid matrix tablets containing a double fixed dose combination of artemisone and lumefantrine

  2018cites this paper
• Lipid Nanocarriers for Advanced Therapeutic Applications

  2018cites this paper
• Lipid Nanocarriers for Intracellular Delivery

  2018cites this paper
• Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics

  2018cites this paper
• Antimalarial activity and metabolism of dihydroartemisinin-derived dimer

  2018cites this paper
• Artesunate-quercetin/luteolin dual drug nanofacilitated synergistic treatment for malaria: A plausible approach to overcome artemisinin combination therapy resistance.

  2017cites this paper
• Nanostructured lipid carriers as oral delivery systems for poorly soluble drugs

  2017cites this paper
• Reduced cardiotoxicity and increased oral efficacy of artemether polymeric nanocapsules in Plasmodium berghei-infected mice

  2017cites this paper